The results here suggest that BCL6B may be an ideal candidate for predicting the progression of both HCC and liver fibrosis, since BCL6B expression was reduced in HCC tissues but enhanced in fibrotic tissues. Here, BCL6B is linked to hepatocellular carcinoma.